Circulating serum miRNAs as diagnostic markers for colorectal cancer

PLoS ONE

Volumn 11, Issue 5, 2016, Pages

  Zekri, Abdel Rahman N ^a   Youssef, Amira Salah El Din ^a   Lotfy, Mai M ^a   Gabr, Reham ^a   Ahmed, Ola S ^a   Nassar, Auhood ^a   Hussein, Nehal ^a   Omran, Dalia ^b   Medhat, Eman ^b   Eid, Salam ^a   Hussein, Marwa Mahmoud ^a   Ismail, Maha Yahia ^a   Alenzi, Faris Q ^c   Bahnassy, Abeer A ^d  

^a CAIRO UNIVERSITY   (Egypt)

^b Cairo University   (Egypt)

^c KING SAUD UNIVERSITY   (Saudi Arabia)

^d NATIONAL CANCER INSTITUTE   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MICRORNA 135A; MICRORNA 135B; MICRORNA 146A; MICRORNA 17; MICRORNA 183; MICRORNA 18A; MICRORNA 19A; MICRORNA 19B; MICRORNA 20A; MICRORNA 21; MICRORNA 223; MICRORNA 24; MICRORNA 454; MICRORNA 92A; UNCLASSIFIED DRUG; TUMOR MARKER;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; CARCINOGENESIS; COLON POLYP; COLONOSCOPY; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; INFLAMMATORY BOWEL DISEASE; MAJOR CLINICAL STUDY; MALE; MICRORNA BLOOD LEVEL; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; UPREGULATION; VALIDATION PROCESS; BLOOD; CASE CONTROL STUDY; COLORECTAL NEOPLASMS; GENETICS; MIDDLE AGED; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; BIOMARKERS, TUMOR; CASE-CONTROL STUDIES; COLONIC POLYPS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; MALE; MICRORNAS; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; ROC CURVE;

EID: 84967317193     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0154130     Document Type: Article

References (32)

1. O'Connell JB, Maggard MA, Ko CY. Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst. 2004; 96:1420-5. PMID: 15467030
2. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2012. CA Cancer J Clin. 2012; 62:10-29. doi:10.3322/caac.20138 PMID: 22237781
3. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010; 60(5):277-300. doi:10.3322/caac.20073 PMID: 20610543
4. Zisman TL, Rubin DT. Colorectal cancer and dysplasia in inflammatory bowel disease. World J Gastroenterol.2008; 14(17): 2662-2669. PMID: 18461651
5. Anderson EC, Wong MH. Caught in the Akt: regulation of Wnt signaling in the intestine. Gastroenterology. 2010; 139: 718-722. doi:10.1053/j.gastro.2010.07.012 PMID: 20659460
6. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004; 116:281-97. PMID: 14744438
7. Calin GA, Sevignani C, Dumitru CD, Hyslop T, Noch E, Yendamuri S, et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. Proc Natl Acad Sci U S A. 2004; 101: 2999-3004. PMID: 14973191
8. Schee K, Fodstad O, Flatmark K. MicroRNAs as biomarkers in colorectal cancer. Am J Pathol. 2010; 177(4):1592-1599. doi:10.2353/ajpath.2010.100024 PMID: 20829435
9. Arndt GM, Dossey L, Cullen LM, Lai A, Druker R, Eisbacher M, et al. Characterization of global micro- RNA expression reveals oncogenic potential of miR-145 in metastatic colorectal cancer. BMC Cancer. 2009; 9:374. doi:10.1186/1471-2407-9-374 PMID: 19843336
10. Peacock O, Lee AC, Larvin M, Tufarelli C, Lund JN. MicroRNAs: relevant tools for a colorectal surgeon? World J Surg. 2012; 36:1881-1892. doi:10.1007/s00268-012-1603-3 PMID: 22526047
11. Wang YX, Zhang XY, Zhang BF, Yang CQ, Chen XM, Gao HJ. Initial study of microRNA expression profiles of colonic cancer without lymph node metastasis. J Dig Dis. 2010; 11(1): 50-54. doi:10.1111/j.1751-2980.2009.00413.x PMID: 20132431
12. Gilad S, Meiri E, Yogev Y, Benjamin S, Lebanony D, Yerushalmi N, et al. Serum microRNAs are promising novel biomarkers. PLOS One. 2008; 3(9), e3148. doi:10.1371/journal.pone.0003148 PMID: 18773077
13. Nagel R, le Sage C, Diosdado B, et al. Regulation of the adenomatous polypsosis coli gene by the miR-135 family in colorectal cancer. Cancer Res. 2008; 68:5795-802. doi:10.1158/0008-5472.CAN-08-0951 PMID: 18632633
14. Koga Y, Yasunaga M, Takahashi A, Kuroda J, Moriya Y, Akasu T, et al. MicroRNA Expression Profiling of Exfoliated Colonocytes Isolated from Feces for Colorectal Cancer Screening. Cancer Prev Res. 2010; 3: 1435.
15. Xu T, Jing C, Shi Y, Miao R, Peng L, Kong S, et al. microRNA-20a enhances the epithelial-to-mesenchymal transition of colorectal cancer cells by modulating matrix metalloproteinases. Exp Ther Med. 2015; 10:683-688. PMID: 26622375
16. Woods K, Thomson JM, Hammond SM. Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors. J Biol Chem. 2007; 282: 2130-2134. PMID: 17135268
17. Ivanovska I, Ball AS, Diaz RL, Magnus JF, Kibukawa M, Schelter JM, et al. MicroRNAs in the miR-106b family regulate p21/CDKN1A and promote cell cycle progression. Mol Cell Biol. 2008; 28: 2167-2174. doi:10.1128/MCB.01977-07 PMID: 18212054
18. Motoyama K, Inoue H, Takatsuno Y, Tanaka F, Mimori K, Uetake H, et al. Over- and under-expressed microRNAs in human colorectal cancer. Int J Oncol. 2009; 34:1069-75. PMID: 19287964
19. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci USA.2006; 103:2257-61. PMID: 16461460
20. Mu P, Han Y-C, Betel D, Yao E, Squatrito M, Ogrodowski P, et al. Genetic dissection of the miR-17-92 cluster of microRNAs in Myc induced B-cell lymphomas. Genes & Dev.2009; 23: 2806-2811.
21. Huang Z, Huang D, Ni S, Peng Z, Sheng W, Du X. Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer. 2010; 127: 118-126. doi:10.1002/ijc.25007 PMID: 19876917
22. Li ZW, Yang YM, Du LT, Dong Z, Wang LL, Zhang X, et al. Overexpression of miR-223 correlates with tumor metastasis and poor prognosis in patients with colorectal cancer. Med Oncol. 2014; 31 (11): 256. doi:10.1007/s12032-014-0256-5 PMID: 25270282
23. Wu L, Li H, Jia CY, Cheng W, Yu M, Peng M, et al. MicroRNA-223 regulates FOXO1 expression and cell proliferation. FEBS Lett. 2012; 586:1038-1043. doi:10.1016/j.febslet.2012.02.050 PMID: 22569260
24. Sun D, Wang C, Long S, Ma Y, Guo Y, Huang Z, et al. C/EBP-β-activated microRNA-223 promotes tumour growth through targeting RASA1 in human colorectal cancer. Br J Cancer. 2015; 112:1491-1500. doi:10.1038/bjc.2015.107 PMID: 25867276
25. Myatt SS, Lam EW. The emerging roles of forkhead box (Fox) proteins in cancer. Nat Rev Cancer. 2007; 7: 847-859. PMID: 17943136
26. Nakae J, Kitamura T, Kitamura Y, Biggs WH 3rd, Arden KC, Accili D. The forkhead transcription factor Foxo1 regulates adipocyte differentiation. Dev Cell. 2003; 4: 119-129 PMID: 12530968
27. McLaughlin SK, Olsen SN, Dake B, De Raedt T, Lim E, Bronson RT, et al. The RasGAP gene, RASAL2, is a tumor and metastasis suppressor. Cancer cell. 2013; 24(3): 365-378. doi:10.1016/j.ccr.2013.08.004 PMID: 24029233
28. Wu CW, Dong YJ, Liang QY, He XQ, Ng SS, Chan FK, et al. MicroRNA-18a attenuates DNA damage repair through suppressing the expression of ataxia telangiectasia mutated in colorectal cancer. PLOS ONE. 2013; 8: e57036. doi:10.1371/journal.pone.0057036 PMID: 23437304
29. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science. 1998; 281 1674-7. PMID: 9733514
30. Kalla R, Ventham NT, Kennedy NA, Quintana JF, Nimmo ER, Buck AH, et al. MicroRNAs: new players in IBD. Gut. 2014; 0:1-14.
31. Gereda JE, Leung DYM, Thatayatikom A, Streib JE, Price MR, Klinnert MD, et al. Relationship between house dust endotoxin exposure, type 1 T-cell development, and allergen sensitisation in infants at high risk of asthma. Lancet. 2000; 355:1680-1683. PMID: 10905243
32. Lawrence T. The nuclear factor NF-kappaB pathway in inflammation. Cold Spring Harb Perspect Biol. 2009; 1:a001651. doi:10.1101/cshperspect.a001651 PMID: 20457564